Bupivacaine Hydrochloride/Fentanyl Citrate

盐酸布比卡因/枸橼酸芬太尼

Report date: 2025/09/26 16:39:26

Base Information

Drug NameBupivacaine Hydrochloride/Fentanyl Citrate
Drug Alias NameBupivacaine Hydrochloride and Fentanyl Citrate盐酸布比卡因枸橼酸芬太尼枸橼酸芬太尼/盐酸布比卡因Fentanyl citrate/Bupivacaine hydrochlorideBufyl
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors agonistsSodium channel alpha subunit blockers
TargetsOpioid receptorsSodium channel alpha subunit
Therapy Area/IndicationsPain
Global Approved IndicationsPain
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date2012/01/01
Country/TerritoryUnited Kingdom
CombinationsYes Bupivacaine HydrochlorideFentanyl Citrate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAmco
China Registration ClassN/A

Develop Information

Active CompaniesAmco
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN01AH51N01BB51
Related LinksN/A